MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-links

Genes and Development

Volumn 29, Issue 18, 2015, Pages 1955-1968

  Jiang, Qinqin ^a   Paramasivam, Manikandan ^b   Aressy, Bernadette ^a   Wu, Junmin ^a   Bellani, Marina ^b   Tong, Wei ^c   Seidman, Michael M ^b   Greenberg, Roger A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

BRCA2; DNA2; Interstrand cross link repair; MERIT40; Ubiquitination

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; MERIT40 PROTEIN; MESSENGER RNA; MITOMYCIN; PROTEIN; RAP80 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; BRCA2 PROTEIN, MOUSE; CELL CYCLE PROTEIN; DNA HELICASE; FANCD2 PROTEIN, MOUSE; MERIT40 PROTEIN, MOUSE; RAP80 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DISEASE EXACERBATION; DNA CROSS LINKING; DNA DAMAGE; DNA END JOINING REPAIR; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; HYPERSENSITIVITY; MOUSE; MUTATION; NONHUMAN; PARSYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; START CODON; UBIQUITINATION; WHOLE BODY RADIATION; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HUMAN; METABOLISM; PROTEIN TRANSPORT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRCA2 PROTEIN; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA HELICASES; DNA REPAIR; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; MICE; MICE, INBRED C57BL; MUTATION; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 84941956000     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.264192.115     Document Type: Article

References (69)

1. Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ. 2012. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol 14: 318-328.
2. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, et al. 2010. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892.
3. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai Y-Y, et al. 2010. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 42: 880-884.
4. Bunting SF, Callén E, Kozak ML, Kim JM, Wong N, López-Contreras AJ, Ludwig T, Baer R, Faryabi RB, Malhowski A, et al. 2012. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cel 46: 125-135.
5. Castillo A, Paul A, Sun B, Huang TH, Wang Y, Yazinski SA, Tyler J, Li L, You MJ, Zou L, et al. 2014. The BRCA1-interacting protein Abraxas is required for genomic stability and tumor suppression. Cell Rep 8: 807-817.
6. Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, et al. 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cel 2: 317-328.
7. Clauson C, Scharer OD, Niedernhofer L. 2013. Advances in understanding the complex mechanisms of DNA interstrand crosslink repair. Cold Spring Harb Perspect Med 5: a012732.
8. Coleman KA, Greenberg RA. 2011. The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem 286: 13669-13680.
9. Cooper EM, Cutcliffe C, Kristiansen TZ, Pandey A, Pickart CM, Cohen RE. 2009. K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J 28: 621-631.
10. Crossan GP, van derWeyden L, Rosado IV, Langevin F, Gaillard PHL, McIntyre RE, Gallagher F, Kettunen MI, Lewis DY, Brindle K, et al. 2011. Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nat Genet 43: 147-152.
11. D’Andrea AD, Grompe M. 2003. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3: 23-34.
12. Deans AJ, West SC. 2011. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 11: 467-480.
13. DomcHek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M, Monteiro ANA, Messick TE, Powers J, Yonker A, et al. 2013. Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discov 3: 399-405.
14. Feng L, Huang J, Chen J. 2009. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev 23: 719-728.
15. Feng L, Wang J, Chen J. 2010. The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by two scaffold proteins localizing in different subcellular compartments. J Biol Chem 285: 30982-30988.
16. Garaycoechea JI, Patel KJ. 2014. Why does the bone marrow fail in Fanconi anemia? Blood 123: 26-34.
17. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, et al. 1996. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56: 5360-5364.
18. Goldstein M, Kastan MB. 2015. Repair versus checkpoint functions of BRCA1 are differentially regulated by site of chromatin binding. Cancer Res 75: 2699-2707.
19. Gudjonsson T, Altmeyer M, Savic V, Toledo L, Dinant C, Grøfte M, Bartkova J, Poulsen M, Oka Y, Bekker-Jensen S, et al. 2012. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150: 697-709.
20. Guzzo CM, Berndsen CE, Zhu J, Gupta V, Datta A, Greenberg RA, Wolberger C, Matunis MJ. 2012. RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage. Sci Signal 5: 88.
21. Hartley JM, Spanswick VJ, Gander M, Giacomini G, Whelan J, Souhami RL, Hartley JA. 1999. Measurement of DNA crosslinking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Clin Cancer Res 5: 507-512.
22. Hu Y, Scully R, Sobhian B, Xie A, Shestakova E, Livingston DM. 2011. RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. Genes Dev 25: 685-700.
23. Hu Y, Petit SA, Ficarro SB, Toomire KJ, Xie A, Lim E, Cao SA, Park E, Eck MJ, Scully R, et al. 2014. PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. Cancer Discov 4: 1430-1447.
24. Huang J, Liu S, Bellani MA, Thazhathveetil AK, Ling C, deWinter JP, Wang Y, Wang W, Seidman MM. 2013. The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks. Mol Cel 52: 434-446.
25. Huen MSY, Sy SMH, Chen J. 2009. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 11: 138-148.
26. Jackson SP, Durocher D. 2013. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cel 49: 795-807.
27. Jackson DA, Pombo A. 1998. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J Cell Biol 140: 1285-1295.
28. Jiang Q, Greenberg RA. 2015. Deciphering the BRCA1 tumor suppressor network. J Biol Chem 290: 17724-17732.
29. Karanja KK, Lee EH, Hendrickson EA, Campbell JL. 2014. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells. Cell Cycle 13: 1540-1550.
30. Kim H, D’Andrea AD. 2012. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26: 1393-1408.
31. Kim H, Yu X. 2007. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316: 1202-1205.
32. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A. 2011. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet 43: 142-146.
33. Kottemann MC, Smogorzewska A. 2013. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 493: 356-363.
34. Kratz K, Schöpf B, Kaden S, Sendoel A, Eberhard R, Lademann C, Cannavo E, Sartori AA, Hengartner MO, Jiricny J. 2010. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 142: 77-88.
35. Li M, Yu X. 2013. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23: 693-704.
36. Long DT, Joukov V, Budzowska M, Walter JC. 2014. BRCA1 promotes unloading of theCMGhelicase from a stalledDNAreplication fork. Mol Cel 56: 174-185.
37. MacKay C, Déclais A-C, Lundin C, Agostinho A, Deans AJ, Macartney TJ, Hofmann K, Gartner A, West SC, Helleday T, et al. 2010. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 142: 65-76.
38. Mattiroli F, Vissers JHA, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, Marteijn JA, Sixma TK. 2012. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 150: 1182-1195.
39. Messick TE, Greenberg RA. 2009. The ubiquitin landscape at DNA double-strand breaks. J Cell Biol 187: 319-326.
40. Moynahan ME, Chiu JW, Koller BH, Jasin M. 1999. Brca1 controls homology-directed DNA repair. Mol Cel 4: 511-518.
41. Neelsen KJ, Lopes M. 2015. Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat Rev Mol Cell Biol 16: 207-220.
42. Nikkilä J, Coleman KA, Morrissey D, Pylkäs K, Erkko H, Messick TE, Karppinen S-M, Amelina A, Winqvist R, Greenberg RA. 2009. Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. Oncogene 28: 1843-1852.
43. Patterson-Fortin J, Shao G, Bretscher H, Messick TE, Greenberg RA. 2010. Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex. J Biol Chem 285: 30971-30981.
44. Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. 2010. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cel 37: 492-502.
45. Ragland RL, Patel S, Rivard RS, Smith K, Peters AA, Bielinsky AK, Brown EJ. 2013. RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells. Genes Dev 27: 2259-2273.
46. Rozenova K, Jiang J, Donaghy R, Aressy B, Greenberg RA, Tong W. 2015. MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling. Blood 125: 1730-1738.
47. Sato Y, Yoshikawa A, Yamashita M, Yamagata A, Fukai S. 2009. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3. EMBOJ 28: 3903-3909.
48. Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J, Dyment DA, Innes AM, Boycott KM, Moreau LA, et al. 2015. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 5: 135-142.
49. Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M. 2011. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145: 529-542.
50. Schlacher K, Wu H, Jasin M. 2012. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22: 106-116.
51. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM. 1996. Location of BRCA1 in human breast and ovarian cancer cells. Science 272: 123-126.
52. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275.
53. Shao G, Patterson-Fortin J, Messick TE, Feng D, Shanbhag N, Wang Y, Greenberg RA. 2009. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA doublestrand breaks. Genes Dev 23: 740-754.
54. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810.
55. Silver DP, Livingston DM. 2001. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cel 8: 233-243.
56. Sims JJ, Cohen RE. 2009. Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of Rap80. Mol Cel 33: 775-783.
57. Smogorzewska A, Desetty R, Saito TT, Schlabach M, Lach FP, Sowa ME, Clark AB, Kunkel TA, Harper JW, Colaiácovo MP, et al. 2010. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cel 39: 36-47.
58. Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, Livingston DM, Greenberg RA. 2007. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316: 1198-1202.
59. Solyom S, Aressy B, Pylkäs K, Patterson-Fortin J, Hartikainen JM, Kallioniemi A, Kauppila S, Nikkilä J, Kosma V-M, Mannermaa A, et al. 2012. Breast cancer-associated Abraxas mutation disrupts nuclear localization andDNAdamage response functions. Sci Transl Med 4: 122-23.
60. Spanswick VJ, Hartley JM, Ward TH, Hartley JA. 1999. Measurement of drug-induced DNAinterstrand crosslinking using the single-cell gel electrophoresis (comet) assay. Methods Mol Med 28: 143-154.
61. Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AWM, et al. 2011. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 43: 138-141.
62. Thangavel S, Berti M, Levikova M, Pinto C, Gomathinayagam S, Vujanovic M, Zellweger R, Zellweger R, Moore H, Moore H, et al. 2015. DNA2 drives processing and restart of reversed replication forks in human cells. J Cell Biol 208: 545-562.
63. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. 2010. Long noncodingRNAas modular scaffold of histone modification complexes. Science 329: 689-693.
64. Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ. 2007. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316: 1194-1198.
65. Wang B, Hurov K, Hofmann K, Elledge SJ. 2009. NBA1, a new player in the Brca1 A complex, is required forDNAdamage resistance and checkpoint control. Genes Dev 23: 729-739.
66. Wu J, Liu C, Chen J, Yu X. 2012. RAP80 protein is important for genomic stability and is required for stabilizing BRCA1-A complex at DNA damage sites in vivo. J Biol Chem 287: 22919-22926.
67. Yin Z, Menendez D, Resnick MA, French JE, Janardhan KS, Jetten AM. 2012. RAP80 is critical in maintaining genomic stability and suppressing tumor development. Cancer Res 72: 5080-5090.
68. Zellweger R, Dalcher D, Mutreja K, Berti M, Schmid JA, Herrador R, Vindigni A, Lopes M. 2015. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J Cell Biol 208: 563-579.
69. Zheng H, Gupta V, Patterson-Fortin J, Bhattacharya S, Katlinski K, Wu J, Varghese B, Carbone CJ, Aressy B, Fuchs SY, et al. 2013. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Rep 5: 180-193.